214 related articles for article (PubMed ID: 17060450)
1. Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops.
Cheng TH; Cohen SN
Mol Cell Biol; 2007 Jan; 27(1):111-9. PubMed ID: 17060450
[TBL] [Abstract][Full Text] [Related]
2. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
Li L; Liao J; Ruland J; Mak TW; Cohen SN
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
Barak Y; Gottlieb E; Juven-Gershon T; Oren M
Genes Dev; 1994 Aug; 8(15):1739-49. PubMed ID: 7958853
[TBL] [Abstract][Full Text] [Related]
4. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
Ofir-Rosenfeld Y; Boggs K; Michael D; Kastan MB; Oren M
Mol Cell; 2008 Oct; 32(2):180-9. PubMed ID: 18951086
[TBL] [Abstract][Full Text] [Related]
5. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
6. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
8. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
[TBL] [Abstract][Full Text] [Related]
9. Defects in transcription coupled repair interfere with expression of p90(MDM2) in response to ultraviolet light.
Michalowski J; Seavey SE; Mendrysa SM; Perry ME
Oncogene; 2001 Sep; 20(41):5856-64. PubMed ID: 11593391
[TBL] [Abstract][Full Text] [Related]
10. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.
Stommel JM; Wahl GM
Cell Cycle; 2005 Mar; 4(3):411-7. PubMed ID: 15684615
[TBL] [Abstract][Full Text] [Related]
11. p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.
Ruland J; Sirard C; Elia A; MacPherson D; Wakeham A; Li L; de la Pompa JL; Cohen SN; Mak TW
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1859-64. PubMed ID: 11172041
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.
Saucedo LJ; Carstens BP; Seavey SE; Albee LD; Perry ME
Cell Growth Differ; 1998 Feb; 9(2):119-30. PubMed ID: 9486848
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
Liang H; Lunec J
Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
[TBL] [Abstract][Full Text] [Related]
14. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
15. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
[TBL] [Abstract][Full Text] [Related]
16. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
17. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
Tamborini E; Della Torre G; Lavarino C; Azzarelli A; Carpinelli P; Pierotti MA; Pilotti S
Int J Cancer; 2001 Jun; 92(6):790-6. PubMed ID: 11351297
[TBL] [Abstract][Full Text] [Related]
19. The p53 isoforms are differentially modified by Mdm2.
Camus S; Ménendez S; Fernandes K; Kua N; Liu G; Xirodimas DP; Lane DP; Bourdon JC
Cell Cycle; 2012 Apr; 11(8):1646-55. PubMed ID: 22487680
[TBL] [Abstract][Full Text] [Related]
20. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
